Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The human tri-peptide GHK and tissue remodeling"
With high purity, excellent stability, and outstanding formulation compatibility, it is suitable for capsules, tablets, powders, gummies, sachets, functional beverages, and cosmetic formulations
Key factors influencing cost include: Regulatory status: Licensed medicines that have undergone full MHRA or EMA approval typically command higher prices than older, off-patent alternatives, reflecting the investment in clinical development and post-marketing surveillance
Another GLP agonist, lixisenatide (which is not approved for obesity), improved motor function in early Parkinsons disease (Meissner WG et al, N Eng J Med 2024;390:11761185)
Human clinical trials in androgenetic alopecia patients have reported modest improvements in hair density (10-20% increases) and hair shaft diameter (5-15% increases) following 6-12 months of daily topical GHK-Cu application, though results generally remain inferior to established treatments including minoxidil or finasteride
US$ 29.41
US$ 29.86
US$ 28.32
